[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Kodiak Sciences Inc (KOD)

Kodiak Sciences Inc (KOD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Kodiak Sciences Announces Recent Business Highlights and First Quarter 2026 Financial Results

PALO ALTO, Calif. , May 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended March 31, 2026.

KOD : 37.02 (-4.34%)
Kodiak Sciences to Present Pipeline Advances and KSI-101 Clinical Data, Including Results from a MESI Cohort in a Tertiary Care Uveitis Practice, at Upcoming Scientific Conferences

PALO ALTO, Calif. , May 1, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing...

KOD : 37.02 (-4.34%)
Kodiak Sciences: When Clinical Progress Stops Excusing the Cash Burn Rate

Barchart Research What to Expect from KOD Earnings KOD Generated April 1, 2026 Current Price $42.81 EPS Estimate $$-0.86 Consensus Rating Moderate Buy Average Move 7.69% Kodiak Sciences: When Clinical...

KOD : 37.02 (-4.34%)
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results

PALO ALTO, Calif. , March 31, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the fourth quarter and full year ended December 31,...

KOD : 37.02 (-4.34%)
Stocks Slump on Iran War and Weakness in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -1.74%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.38%. June...

AMAT : 436.62 (-0.89%)
GOOGL : 396.78 (-1.07%)
MPC : 255.03 (+2.50%)
AAPL : 300.23 (+0.68%)
B : 40.61 (-5.91%)
AVGO : 425.19 (-3.32%)
SNDK : 1,407.61 (+1.80%)
HL : 17.64 (-9.31%)
CDE : 17.61 (-9.23%)
ADI : 417.49 (-2.18%)
BF.B : 26.38 (+1.11%)
$IUXX : 29,125.20 (-1.54%)
Iran Ceasefire Skepticism Weighs on Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down -0.64%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.05%. June E-mini S&P futures...

AMAT : 436.62 (-0.89%)
GOOGL : 396.78 (-1.07%)
SNDK : 1,407.61 (+1.80%)
HL : 17.64 (-9.31%)
CDE : 17.61 (-9.23%)
$IUXX : 29,125.20 (-1.54%)
ASML : 1,501.81 (-5.22%)
ZNM26 : 108-315 (-0.17%)
ESM26 : 7,388.00 (-0.60%)
STX : 795.47 (-1.15%)
WDC : 482.02 (-1.46%)
LRCX : 284.72 (-4.82%)
Stocks Fall as Crude Oil Jumps on Doubts About a Ceasefire in Iran

The S&P 500 Index ($SPX ) (SPY ) today is down -0.50%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.77%. June E-mini S&P futures...

AMAT : 436.62 (-0.89%)
B : 40.61 (-5.91%)
AVGO : 425.19 (-3.32%)
SNDK : 1,407.61 (+1.80%)
HL : 17.64 (-9.31%)
CDE : 17.61 (-9.23%)
$IUXX : 29,125.20 (-1.54%)
ASML : 1,501.81 (-5.22%)
ZNM26 : 108-315 (-0.17%)
ESM26 : 7,388.00 (-0.60%)
STX : 795.47 (-1.15%)
WDC : 482.02 (-1.46%)
Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkudaâ„¢ (tarcocimab tedromer) Over Sham

PALO ALTO, Calif. , March 26, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing...

KOD : 37.02 (-4.34%)
Kodiak Sciences Faces Critical Test as Losses Mount and Analyst Confidence Wavers

Barchart Research What to Expect from KOD Earnings KOD Generated March 25, 2026 Current Price $22.75 EPS Estimate $-1.02 Consensus Rating Moderate Buy Average Move 7.69% Kodiak Sciences Faces Critical...

KOD : 37.02 (-4.34%)
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026

PALO ALTO, Calif. , Feb. 4, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing...

KOD : 37.02 (-4.34%)

Barchart Exclusives

Microsoft Stock Is an AI Bargain That Investors Are Missing
Microsoft trades at a more attractive valuation relative to peers like Alphabet and Amazon. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.